CAM Erkelens - Concepedia

Author

CAM Erkelens

Vrije Universiteit Amsterdam

Also Known As

C A Erkelens, C A M Erkelens, C Erkelens, C. Erkelens, C.A.M Erkelens, C.A.M. Erkelens, CAM Erkelens

Publications

327

Citations

H-Index

Concepts

All Affiliations

Vrije Universiteit Amsterdam University of Amsterdam BioNumerik (United States)

About

CAM Erkelens is an author at Vrije Universiteit Amsterdam specializing in medicine, pharmacology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	294
2	Cell Biology	2	2	56
3	Natural Sciences	1	1	27
4	Biochemistry	1	1	27
5	Hepatology	1	1	24

CAM Erkelens

Publications

311

Citations

H-Index

Page 1

	Year	Citations
The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer Epie Boven, Hyman M. Schipper, CAM Erkelens, British Journal of Cancer Experimental Human CancerOncologyAnti-tumour EfficacyMedicinePharmacotherapy	1993	108
BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts Epie Boven, Miranda Verschraagen, T.M. Hulscher, European Journal of Cancer Tumor BiologyOncologyHuman Tumour XenograftsMedicineAnti-cancer Agent	2002	39
The efficacy of the anthracycline prodrug daunorubicin-GA3 in human ovarian cancer xenografts PHJ Houba, Epie Boven, CAM Erkelens, British Journal of Cancer OncologyEndocrine-related CancerMedicineGynecologyPharmacotherapy	1998	32
Non-linear pharmacokihetics of 5-fluorouracil as described by in vivo behaviour of 5,6 dihydro-5-fluorouracil E. A. de Bruijn, L. Remeyer, U. R. Tjaden, Biochemical Pharmacology Medicinal ChemistryPharmaceutical ScienceBioorganic ChemistryPharmacological StudyBiochemistry	1986	27
Antitumor activity of taxotere (RP 56976, NSC 628503), a new taxol analog, in experimental ovarian cancer Epie Boven, E. Venema-Gaberscek, CAM Erkelens, Annals of Oncology Medicinal ChemistryAntitumor ActivityExperimental Ovarian CancerMedicinePharmacology	1993	25
Pharmacological evaluation of experimental isolated liver perfusion and hepatic artery infusion with 5-fluorouracil. L. M. de Brauw, Andreas Marinelli, C J van de Velde, PubMed PathologyPharmacotherapyIsolated Liver PerfusionPharmacological StudyToxicology	1991	24
The anti-tumour effects of the prodrugs N-l-leucyl-doxorubicin and vinblastine-isoleucinate in human ovarian cancer xenografts Epie Boven, HR Hendriks, CAM Erkelens British Journal of Cancer MedicinePharmacologyAnti-tumour EffectsPharmacotherapyAnti-cancer Agent	1992	22
Activity of GR30921X (NSC 382057) and GR63178A (NSC D611615) in human ovarian cancer lines Epie Boven, CAM Erkelens, M Lüning, British Journal of Cancer Nsc 382057Oncogenic AgentMedicineGynecologyCancer Cell Biology	1990	17
Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats Miranda Verschraagen, Epie Boven, Emine Torun, British Journal of Cancer	2004	17

Page 1